Lamivudine and alpha-interferon in combination long term for precore mutant chronic hepatitis B

This publication has 28 references indexed in Scilit:

• Efficacy of Lamivudine in Patients With Hepatitis B E Antigen-Negative/Hepatitis B Virus Dna-Positive (Precore Mutant) Chronic Hepatitis Befficacy of Lamivudine in Patients With Hepatitis B E Antigen-Negative/Hepatitis B Virus Dna-Positive (Precore Mutant) Chronic Hepatitis Befficacy of Lamivudine in Patients With Hepatitis B E Antigen-Negative/Hepatitis B Virus Dna-Positive (Precore Mutant) Chronic Hepatitis Befficacy of Lamivudine in Patients With Hepatitis B E Antigen-Negative/Hepatitis B Virus Dna-Positive (Precore Mutant) Chronic Hepatitis Bb
  Hepatology, 1999
• Lamivudine Therapy for Hepatitis B Infection
  Scandinavian Journal of Gastroenterology, 1999
• A One-Year Trial of Lamivudine for Chronic Hepatitis B
  New England Journal of Medicine, 1998
• The Treatment of Chronic Viral Hepatitis
  New England Journal of Medicine, 1997
• Analysis of hepatitis B virus genotypes and pre-core region variability during interferon treatment of HBe antigen negative chronic hepatitis B
  Journal of Medical Virology, 1996
• Hepatitis B virus unable to secrete e antigen and response to interferon in chronic hepatitis B
  Gastroenterology, 1993
• Anti-HBe-positive chronic hepatitis B with HBV-DNA in the serum response to a 6-month course of lymphoblastoid interferon
  Journal of Hepatology, 1992
• Precore mutant hepatitis B virus infection and liver disease
  Gastroenterology, 1992
• Natural course and response to interferon of chronic hepatitis B accompanied by antibody to hepatitis B e antigen
  Hepatology, 1989
• The development of cirrhosis in patients with chronic type B hepatitis: A prospective study
  Hepatology, 1988